miR-155 in cancer drug resistance and as target for miRNA-based therapeutics

MicroRNAs: Target Recognition and Regulatory Functions

Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · see citing works

A microRNA expression signature of human solid tumors defines cancer gene targets

Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697 · see citing works

Regulation of microRNA biogenesis

Ha, M., & Kim, V. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3838 · Cited by 5,462 · see citing works

PD-1 and Its Ligands in Tolerance and Immunity

Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378 · see citing works

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Herbst, R. S., Soria, J.-C., Kowanetz, M., Fine, G. D., Hamid, O., Gordon, M. S., Sosman, J. A., McDermott, D. F., Powderly, J. D., Gettinger, S. N., et al. (2014) · Nature · doi:10.1038/nature14011 · Cited by 5,231 · see citing works

NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317 · cited 3× · see citing works

Frequent deletions and down-regulation of micro- RNA genes <i>miR15</i> and <i>miR16</i> at 13q14 in chronic lymphocytic leukemia

Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 4,269 · see citing works

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023 · see citing works

Identification of tissue-specific microRNAs from mouse

Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., & Tuschl, T. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00809-6 · Cited by 2,859 · see citing works

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

Powles, T. B., Eder, J. P., Fine, G. D., Braiteh, F. S., Loriot, Y., Cruz, C., Joaquim Bellmunt, B., Burris, H. A., Petrylak, D. P., Teng, S.-L. M., et al. (2014) · Nature · doi:10.1038/nature13904 · Cited by 2,383 · see citing works

International Journal of Oncology

(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,332 · see citing works

MicroRNA-155 is induced during the macrophage inflammatory response

O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866 · see citing works

Requirement of <i>bic/microRNA-155</i> for Normal Immune Function

Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van Dongen, S., Grocock, R. J., Das, P. P., Miska, E. A., et al. (2007) · Science · doi:10.1126/science.1139253 · Cited by 1,833 · see citing works

Identification of hundreds of conserved and nonconserved human microRNAs

Bentwich, I., Avniel, A., Karov, Y., Aharonov, R., Gilad, S., Barad, O., Barzilai, A., Einat, P., Einav, U., Meiri, E., et al. (2005) · Nature Genetics · doi:10.1038/ng1590 · Cited by 1,465 · see citing works

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

Eis, P. S., Tam, W., Sun, L., Chadburn, A., Li, Z., Gomez, M. F., Lund, E., & Dahlberg, J. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500613102 · Cited by 1,322 · see citing works

Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice

Costinean, S., Zanesi, N. A. O., Pekarsky, Y., Tili, E., Volinia, S., Heerema, N. A., & Croce, C. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602266103 · Cited by 952 · see citing works

Inositol phosphatase SHIP1 is a primary target of miR-155

O'Connell, R. M., Chaudhuri, A. A., Rao, D. S., & Baltimore, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902636106 · Cited by 826 · see citing works

Foxp3-Dependent MicroRNA155 Confers Competitive Fitness to Regulatory T Cells by Targeting SOCS1 Protein

Lu, L., Thai, T., Calado, D. P., Chaudhry, A., Kubo, M., Tanaka, K., Loeb, G. B., Lee, H., Yoshimura, A., Rajewsky, K., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.010 · Cited by 784 · see citing works

microRNA-155 Regulates the Generation of Immunoglobulin Class-Switched Plasma Cells

Vigorito, E., Perks, K. L., Abreu‐Goodger, C., Bunting, S., Xiang, Z., Kohlhaas, S. L., Das, P. P., Miska, E. A., Rodriguez, A., Bradley, A., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.10.009 · Cited by 763 · see citing works

MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the <i>Suppressor of Cytokine Signaling 1</i> Gene

Jiang, S., Zhang, H.-W., Lu, M.-H., He, X.-H., Li, Y., Gu, H., Liu, M.-F., & Wang, E.-D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4250 · Cited by 679 · see citing works

BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas

Kluiver, J. L., Poppema, S., de Jong, D., Blokzijl, T., Harms, G., Jacobs, S. C., Kroesen, B., & van den Berg, A. (2005) · The Journal of Pathology · doi:10.1002/path.1825 · Cited by 672 · see citing works

miR-155 gene: A typical multifunctional microRNA

Faraoni, I., Antonetti, F. R., Cardone, J., & Bonmassar, E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.013 · Cited by 672 · see citing works

MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis

Kurowska‐Stolarska, M., Alivernini, S., Ballantine, L. E., Asquith, D. L., Millar, N. L., Gilchrist, D. S., Reilly, J. H., Ierna, M. X., Fraser, A. R., Stolarski, B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019536108 · Cited by 639 · see citing works

Transcription factors in myeloid development: balancing differentiation with transformation

Rosenbauer, F., & Tenen, D. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2024 · Cited by 606 · cited 1× · see citing works

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

Gironella, M., Seux, M., Xie, M.-J., Cano, C. E., Tomasini, R., Gommeaux, J., Garcia, S., Nowak, J., Yeung, M. L., Jeang, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703942104 · Cited by 548 · see citing works

Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin

Garzon, R., Garofalo, M., Martelli, M. P., Briesewitz, R., Wang, L., Fernandez-Cymering, C., Volinia, S., Liu, C., Schnittger, S., Haferlach, T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800135105 · Cited by 500 · see citing works

Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia

Fulci, V., Chiaretti, S., Goldoni, M., Azzalin, G., Carucci, N., Tavolaro, S., Castellano, L., Magrelli, A., Citarella, F., Messina, M., et al. (2007) · Blood · doi:10.1182/blood-2006-12-062398 · Cited by 498 · see citing works

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

Babar, I., Cheng, C. J., Booth, C. J., Liang, X., Weidhaas, J. B., Saltzman, W. M., & Slack, F. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201516109 · Cited by 496 · see citing works

CD34+ hematopoietic stem-progenitor cell microRNA expression and function: A circuit diagram of differentiation control

Georgantas, R. W., Hildreth, R. L., Morisot, S., Alder, J. K., Liu, C., Heimfeld, S., Calin, G. A., Croce, C. M., & Civin, C. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610983104 · Cited by 492 · see citing works

Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer

Kong, W. W., He, L., Richards, E. J., Challa, S., Cx, X., Permuth‐Wey, J., Lancaster, J., Coppola, D., Sellers, T. A., Djeu, J. Y., et al. (2013) · Oncogene · doi:10.1038/onc.2012.636 · Cited by 422 · see citing works

Microrna expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphoma

Lawrie, C. H., Soneji, S., Marafioti, T., Cooper, C. D. O., Palazzo, S., Paterson, J. C., Cattan, H., Enver, T., Mager, R., Boultwood, J., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22800 · Cited by 410 · see citing works

miR-155 : On the Crosstalk Between Inflammation and Cancer

Tili, E., Croce, C. M., & Michaille, J. (2009) · International Reviews of Immunology · doi:10.1080/08830180903093796 · Cited by 343 · see citing works

Cell-to-cell communication: microRNAs as hormones.

Bayraktar, R., Van Roosbroeck, K., & Calin, G. A. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12144 · Cited by 316 · see citing works

Src homology 2 domain–containing inositol-5-phosphatase and CCAAT enhancer-binding protein β are targeted by miR-155 in B cells of Eμ-MiR-155 transgenic mice

Costinean, S., Sandhu, S. K., Pedersen, I. M., Tili, E., Trotta, R., Perrotti, D., Ciarlariello, D., Neviani, P., Harb, J. G., Kauffman, L. R., et al. (2009) · Blood · doi:10.1182/blood-2009-05-220814 · Cited by 292 · see citing works

MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma

Mikamori, M., Yamada, D., Eguchi, H., Hasegawa, S., Kishimoto, T., Tomimaru, Y., Asaoka, T., Noda, T., Wada, H., Kawamoto, K., et al. (2017) · Scientific Reports · doi:10.1038/srep42339 · Cited by 269 · see citing works

Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA

Tam, W. (2001) · Gene · doi:10.1016/s0378-1119(01)00612-6 · Cited by 265 · see citing works

Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK

Patel, G. K., Khan, M. A., Bhardwaj, A., Srivastava, S. K., Zubair, H., Patton, M. C., Singh, S., Khushman, M. M., & Singh, A. P. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.18 · Cited by 265 · see citing works

MicroRNAs and chromosomal abnormalities in cancer cells

Calin, G. A., & Croce, C. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209910 · Cited by 262 · see citing works

Epstein–Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-κB pathway

Gatto, G., Rossi, A., Rossi, D. P., Kroening, S., Bonatti, S., & Mallardo, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn666 · Cited by 254 · see citing works

Mutator activity induced by microRNA-155 ( miR-155 ) links inflammation and cancer

Tili, E., Michaille, J., Wernicke, D., Alder, H., Costinean, S., Volinia, S., & Croce, C. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101795108 · Cited by 227 · see citing works

Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155

Chang, S., Wang, R., Akagi, K., Kim, K.-A., Martin, B. K., Cavallone, L., Haines, D. C., Basik, M., Mai, P., Poggi, E. A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2459 · Cited by 224 · see citing works

Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia

Ferrajoli, A., Shanafelt, T. D., Ivan, C., Shimizu, M., Rabe, K. G., Nouraee, N., Ikuo, M., Ghosh, A. K., Lerner, S. A., Rassenti, L. Z., et al. (2013) · Blood · doi:10.1182/blood-2013-01-478222 · Cited by 217 · see citing works

Epstein-Barr Virus-Induced miR-155 Attenuates NF-κB Signaling and Stabilizes Latent Virus Persistence

Lu, F. Y., Weidmer, A., Liu, C., Volinia, S., Croce, C. M., & Lieberman, P. M. (2008) · Journal of Virology · doi:10.1128/jvi.00752-08 · Cited by 212 · see citing works

Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation

Gasparini, P., Lovat, F., Fassan, M., Casadei, L., Cascione, L., Jacob, N. K., Carasi, S., Palmieri, D., Costinean, S., Shapiro, C. L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402604111 · Cited by 210 · see citing works

Onco‐miR‐155 targets SHIP1 to promote TNFα‐dependent growth of B cell lymphomas

Pedersen, I. M., Otero, D. C., Kao, E., Miletic, A. V., Hother, C., Ralfkiaer, E. M., Rickert, R. C., Grønbæk, K., & David, M. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900028 · Cited by 209 · see citing works

MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia

Cui, B., Chen, L., Zhang, S., Mráz, M., Fecteau, J.-F., Yu, J., Ghia, E. M., Zhang, L., Bao, L., Rassenti, L. Z., et al. (2014) · Blood · doi:10.1182/blood-2014-03-559690 · Cited by 208 · see citing works

Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis

Masaki, S., Ohtsuka, R., Abe, Y., Muta, K., & Umemura, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.077 · Cited by 205 · see citing works

T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC

Haasch, D. L., Chen, Y., Reilly, R. M., Chiou, X. G., Koterski, S., Smith, M. L., Kroeger, P., McWeeny, K., Halbert, D. N., Mollison, K. W., et al. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(02)00506-3 · Cited by 190 · see citing works

MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN

Xue, X., Liu, Y., Wang, Y., Meng, M., Wang, K., Zang, X., Zhao, S., Sun, X., Cui, L., Pan, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13022 · Cited by 187 · see citing works

Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers

Roosbroeck, K. V., Fanini, F., Setoyama, T., Ivan, C., Rodriguez‐Aguayo, C., Fuentes‐Mattei, E., Xiao, L., Vannini, I., Redis, R. S., D’Abundo, L., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1025 · Cited by 178 · see citing works

Mutant p53 drives invasion in breast tumors through up-regulation of miR-155

Neilsen, P. M., Noll, J. E., Mattiske, S., Bracken, C. P., Gregory, P. A., Schulz, R. B., Lim, S. P., Kumar, R., Suetani, R. J., Goodall, G. J., et al. (2012) · Oncogene · doi:10.1038/onc.2012.305 · Cited by 167 · see citing works

Micro RNA ‐155‐5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI 3K/Akt pathway

Fu, X., Wen, H., Li, J., Yang, Y., Wang, W., Liang, X., Nan, K., Yao, Y., & Tian, T. (2017) · Cancer Science · doi:10.1111/cas.13177 · Cited by 162 · see citing works

MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer

Johansson, J., Berg, T., Kurzejamska, E., Pang, M.-F., Tabor, V., Jansson, M., Roswall, P., Pietras, K., Sund, M., Religa, P., et al. (2013) · Oncogene · doi:10.1038/onc.2013.322 · Cited by 154 · see citing works

MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia

Vargová, K., Čuřík, N., Burda, P., Bašová, P., Kulvait, V., Pospíšil, V., Savvulidi, F. G., Kokavec, J., Nečas, E., Berková, A., et al. (2011) · Blood · doi:10.1182/blood-2010-05-285064 · Cited by 144 · see citing works

MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase

Bayraktar, R., Pichler, M., Kanlikilicer, P., Ivan, C., Bayraktar, E., Kahraman, N., Aslan, B., Oğuztüzün, S., Ulaşlı, M., Arslan, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14264 · Cited by 138 · see citing works

NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia

Gerloff, D., Grundler, R., Wurm, A. A., Bräuer-Hartmann, D., Katzerke, C., Hartmann, J.-U., Madan, V, Müller-Tidow, C., Duyster, J., Tenen, D. G., et al. (2015) · Leukemia · doi:10.1038/leu.2014.231 · Cited by 135 · see citing works

miRNAs and long noncoding RNAs as biomarkers in human diseases

Roosbroeck, K. V., Pollet, J. B. K., & Călin, G. A. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.12.134 · Cited by 135 · see citing works

Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma

Kluiver, J. L., van den Berg, A., de Jong, D., Blokzijl, T., Harms, G., Bouwman, E., Jacobs, S. C., Poppema, S., & Kroesen, B. J. (2006) · Oncogene · doi:10.1038/sj.onc.1210147 · Cited by 135 · see citing works

Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells

Kanlikilicer, P., Rashed, M. H., Bayraktar, R., Mitra, R., Ivan, C., Aslan, B., Zhang, X., Filant, J., da Silva, A. M., Rodriguez‐Aguayo, C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0714 · Cited by 135 · see citing works

microRNAs as cancer therapeutics: A step closer to clinical application.

Ivković, T. C., Voss, G., Cornellà, H., & Ceder, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.007 · Cited by 135 · see citing works

MicroRNA-155 induction via TNF-α and IFN-γ suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells

Yee, D., Shah, K., Coles, M. C., Sharp, T. V., & Lagos, D. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.809053 · Cited by 132 · see citing works

Quantitative Proteomics Reveals that miR-155 Regulates the PI3K-AKT Pathway in Diffuse Large B-Cell Lymphoma

Huang, X., Shen, Y., Liu, M., Bi, C., Jiang, C., Iqbal, J., McKeithan, T. W., Chan, W. C., Ding, S., & Fu, K. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.03.013 · Cited by 131 · see citing works

miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eµ-miR-155 transgenic mouse model

Sandhu, S. K., Volinia, S., Costinean, S., Galasso, M., Neinast, R., Santhanam, R., Parthun, M. R., Perrotti, D., Marcucci, G., Garzon, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213764109 · Cited by 130 · see citing works

Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells

Babar, I., Czochor, J. R., Steinmetz, A., Weidhaas, J. B., Glazer, P. M., & Slack, F. J. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.10.17681 · Cited by 127 · see citing works

miR-155 Drives Telomere Fragility in Human Breast Cancer by Targeting TRF1

Dinami, R., Ercolani, C., Petti, E., Piazza, S., Ciani, Y., Sestito, R., Sacconi, A., Biagioni, F., le Sage, C., Agami, R., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2038 · Cited by 127 · see citing works

Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex‐determining region Y box 6 in hepatocellular carcinoma

Xie, Q., Chen, X., Lu, F., Zhang, T., Hao, M., Wang, Y., Zhao, J., McCrae, M. A., & Zhuang, H. (2011) · Cancer · doi:10.1002/cncr.26566 · Cited by 118 · see citing works

Oncogenic MicroRNA-155 Down-regulates Tumor Suppressor CDC73 and Promotes Oral Squamous Cell Carcinoma Cell Proliferation

Rather, M. I., Nagashri, M. N., Swamy, S. S., Gopinath, K. S., & Kumar, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.425736 · Cited by 118 · see citing works

MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression

Zang, Y.-S., Zhong, Y.-F., Fang, Z., Li, B., & An, J. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.60 · Cited by 107 · see citing works

MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia

Palma, C. A., Sheikha, D. A., Lim, T. K., Bryant, A. J., Vu, T. T., Jayaswal, V., & Ma, D. D. F. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-79 · Cited by 105 · see citing works

Host miR155 Promotes Tumor Growth through a Myeloid-Derived Suppressor Cell–Dependent Mechanism

Chen, S., Wang, L., Fan, J., Ye, C., Dominguez, D., Zhang, Y., Curiel, T. J., Fang, D., Kuzel, T. M., & Zhang, B. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2331 · Cited by 101 · see citing works

Cisplatin Sensitivity Mediated by WEE1 and CHK1 Is Mediated by miR-155 and the miR-15 Family

Pouliot, L. M., Chen, Y., Bai, J., Guha, R., Martin, S. E., Gottesman, M. M., & Hall, M. D. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1400 · Cited by 101 · see citing works

miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors

Marsigliante, S. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1420 · Cited by 100 · see citing works

MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer.

Shen, R., Wang, Y., Wang, C., Yin, M., Liu, H., Chen, J., Han, J., & Wang, W.-B. (2015) · Europe PMC (PubMed Central) · Cited by 97 · see citing works

miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT

Xiang, X., Zhuang, X., Ju, S., Zhang, S., Jiang, H., Mu, J., Zhang, L., Miller, D. M., Grizzle, W. E., & Zhang, H. (2011) · Oncogene · doi:10.1038/onc.2011.54 · Cited by 96 · see citing works

MicroRNA-155 as a proinflammatory regulator via SHIP-1 down-regulation in acute gouty arthritis

Jin, H. M., Kim, T., Choi, J., Kim, M., Cho, Y., Nam, K. I., Kee, S., Moon, J. B., Choi, S., Park, D.-J., et al. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4531 · Cited by 90 · see citing works

Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma

Zhang, M., Zhou, X., Wang, B., Yung, B. C., Lee, L. J., Ghoshal, K., & Lee, R. J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.020 · Cited by 87 · see citing works

NF-κB–driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance

Chiu, C., Chang, Y.-W., Kuo, K.-T., Shen, Y.-S., Liu, C., Yu, Y., Cheng, C.-C., Lee, K., Chen, F., Hsu, M.-K., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522612113 · Cited by 82 · see citing works

Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia

Khalife, J., Radomska, H. S., Santhanam, R., Huang, X., Neviani, P., Saultz, J. N., Wang, H., Wu, Y.-Z., Alachkar, H., Anghelina, M. I., et al. (2015) · Leukemia · doi:10.1038/leu.2015.106 · Cited by 81 · see citing works

Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage

Zhu, M., Yi, M., Kim, C. H., Deng, C., Li, Y., Medina, D., Stephens, R. M., & Green, J. E. (2011) · Genome biology · doi:10.1186/gb-2011-12-8-r77 · Cited by 75 · see citing works

miR-155 regulates HGAL expression and increases lymphoma cell motility

Dagan, L. N., Jiang, X., Bhatt, S., Cubedo, E., Rajewsky, K., & Lossos, I. S. (2011) · Blood · doi:10.1182/blood-2011-08-370536 · Cited by 72 · see citing works

Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell death

Bhattacharya, S., Chalk, A. M., Ng, A. J. M., Martin, T. J., Zannettino, A. C. W., Purton, L. E., Lü, J., Baker, E. K., & Walkley, C. R. (2016) · Oncogene · doi:10.1038/onc.2016.68 · Cited by 72 · see citing works

MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status

Faraoni, I., Laterza, S., Ardiri, D., Ciardi, C., Fazi, F., & Lo‐Coco, F. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-26 · Cited by 71 · see citing works

miR‐155 Regulates Glioma Cells Invasion and Chemosensitivity by p38 Isforms In Vitro

Liu, Q., Zou, R., Zhou, R., Gong, C., Wang, Z., Cai, T., Tan, C., & Fang, J. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25073 · Cited by 66 · see citing works

miR-155 promotes FLT3-ITD–induced myeloproliferative disease through inhibition of the interferon response

Wallace, J. A., Kagele, D., Eiring, A. M., Kim, C. N., Hu, R., Runtsch, M. C., Alexander, M., Huffaker, T. B., Lee, S.-H., Patel, A. B., et al. (2017) · Blood · doi:10.1182/blood-2016-09-740209 · Cited by 66 · see citing works

Morin promotes prostate cancer cells chemosensitivity to paclitaxel through miR-155/GATA3 axis

Li, B., Jin, X., Hui-lin, M. E. N. G., Hu, B., Zhang, T., Jiang, Y. L., Chen, S., Guo, X., Wang, W., Jiang, W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18133 · Cited by 66 · see citing works

Involvement of miR-155/FOXO3a and miR-222/PTEN in acquired radioresistance of colorectal cancer cell line

Manoochehri, H., Afshar, S., Pashaki, A. S., Mahdavinezhad, A., Nikzad, S., Najafi, R., Amini, R., Gholami, M. H., Khoshghadam, A., & Saidijam, M. (2017) · Japanese Journal of Radiology · doi:10.1007/s11604-017-0679-y · Cited by 66 · see citing works

Adrenaline promotes cell proliferation and increases chemoresistance in colon cancer HT29 cells through induction of miR-155

Pu, J., Bai, D., Yang, X., Lu, X., Xu, L., & Lu, J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.09.126 · Cited by 64 · see citing works

Functionally distinct roles for different miR-155 expression levels through contrasting effects on gene expression, in acute myeloid leukaemia

Narayan, N., Morenos, L., Phipson, B., Willis, S. N., Brumatti, G., Eggers, S., Lalaoui, N., Brown, L. M., Kosasih, H. J., Bartolo, R. C., et al. (2016) · Leukemia · doi:10.1038/leu.2016.279 · Cited by 64 · see citing works

miR-125b and miR-155 Contribute to BCL2 Repression and Proliferation in Response to CD40 Ligand (CD154) in Human Leukemic B-cells

Willimott, S., & Wagner, S. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.285718 · Cited by 63 · see citing works

Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs

Rashed, M. H., Kanlikilicer, P., Rodriguez‐Aguayo, C., Pichler, M., Bayraktar, R., Bayraktar, E., Ivan, C., Filant, J., da Silva, A. M., Aslan, B., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15525 · Cited by 63 · see citing works

Inhibition of miR-155, a therapeutic target for breast cancer, prevented in cancer stem cell formation

Zuo, J., Yu, Y., Zhu, M., Jing, W., Yu, M., Chai, H., Liang, C., & Tu, J. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170642 · Cited by 63 · see citing works

MiR‐155 targets TP53INP1 to regulate liver cancer stem cell acquisition and self‐renewal

Liu, F., Kong, X., Lv, L., & Gao, J. X. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.01.009 · Cited by 62 · see citing works

MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1

Peng, Y., Dong, W., Lin, T., Zhong, G., Liao, B., Wang, B., Gu, P., Huang, L., Xie, Y., Lu, F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3755 · Cited by 61 · see citing works

miR-155 mediates arsenic trioxide resistance by activating Nrf2 and suppressing apoptosis in lung cancer cells

Gu, S., Lai, Y., Chen, H., Liu, Y., & Zhang, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-06061-x · Cited by 60 · see citing works

Up-regulated miR155 Reverses the Epithelial-mesenchymal Transition Induced by EGF and Increases Chemo-sensitivity to Cisplatin in Human Caski Cervical Cancer Cells

Cui, L., Wang, Y., Huang, Y., Yu, H., Huang, Y., Wu, L., & Huang, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052310 · Cited by 59 · see citing works

MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoA

Al-Haidari, A. A., Syk, I., & Thorlacius, H. (2017) · Oncotarget · doi:10.18632/oncotarget.14841 · Cited by 59 · see citing works

Epstein–Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1

Kim, J. H., Kim, W. S., & Park, C. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.659736 · Cited by 58 · see citing works

Oncogenic role of miR ‐155 in anaplastic large cell lymphoma lacking the t(2;5) translocation

Merkel, O., Hamacher, F., Griessl, R., Grabner, L., Schiefer, A., Prutsch, N., Baer, C. R., Egger, G., Schlederer, M., Krenn, P. W., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4539 · Cited by 54 · see citing works

miR-155 mediates drug resistance in osteosarcoma cells via inducing autophagy

Lu, C., Jiang, K., Jiang, H., & WEI, P. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1752 · Cited by 54 · see citing works

Effect of miR-155 knockdown on the reversal of doxorubicin resistance in human lung cancer A549/dox cells

Lv, L.-X., An, X., Li, H., & MA, L. (2015) · Oncology Letters · doi:10.3892/ol.2015.3995 · Cited by 54 · see citing works

Preliminary Results of a Phase 1 Trial Evaluating MRG-106, a Synthetic microRNA Antagonist (LNA antimiR) of microRNA-155, in Patients with CTCL

Querfeld, C., Pacheco, T. R., Foss, F. M., Halwani, A. S., Porcu, P., Seto, A. G., Ruckman, J., Landry, M. L., Jackson, A. L., Pestano, L. A., et al. (2016) · Blood · doi:10.1182/blood.v128.22.1829.1829 · Cited by 51 · see citing works

MiRNA-155 promotes proliferation by targeting caudal-type homeobox 1 (CDX1) in glioma cells

Yang, L., Li, C., Liang, F., Fan, Y., & Zhang, S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.088 · Cited by 50 · see citing works

MiR‐155 inhibits proliferation and invasion by directly targeting PDCD 4 in non‐small cell lung cancer

Liu, F., Song, D., Wu, Y., Liu, X., Zhu, J., & Tang, Y. (2017) · Thoracic Cancer · doi:10.1111/1759-7714.12492 · Cited by 47 · see citing works

Angiotensin II type I receptor and miR-155 in endometrial cancers: Synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells

Choi, C. H., Park, Y.-A., Choi, J., Song, T., Song, S. Y., Lee, Y.-Y., Lee, J., Kim, T., Kim, B., & Bae, D. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.04.020 · Cited by 46 · see citing works

miR-155 regulates the proliferation and cell cycle of colorectal carcinoma cells by targeting E2F2

Li, T., Yang, J., Lv, X., Liu, K., Gao, C., Xing, Y., & Xi, T. (2014) · Biotechnology Letters · doi:10.1007/s10529-014-1540-3 · Cited by 45 · see citing works

Transforming Growth Factor β1/Smad4 Signaling Affects Osteoclast Differentiation via Regulation of miR-155 Expression

Zhao, H., Zhang, J., Shao, H., Liu, J., Jin, M., Chen, J., & Huang, Y. (2017) · Molecules and Cells · doi:10.14348/molcells.2017.2303 · Cited by 44 · see citing works

HOXA9 regulates miR-155 in hematopoietic cells

Hu, Y., Fong, S., Largman, C., & Shen, W.-F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq337 · Cited by 43 · see citing works

FOXO Transcription Factors Enforce Cell Cycle Checkpoints and Promote Survival of Hematopoietic Cells after DNA Damage

Lei, H., & Quelle, F. W. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0531 · Cited by 43 · see citing works

Inhibition of microRNA-155 sensitizes lung cancer cells to irradiation via suppression of HK2-modulated glucose metabolism

Lv, X., Li, Y., Zhang, J., Han, P., & Li, C. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5394 · Cited by 43 · see citing works

MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?

Roosbroeck, K. V., & Călin, G. A. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.02.015 · Cited by 39 · see citing works

Erratum to: Transforming Growth Factor b1/Smad4 Signaling Affects Osteoclast Differentiation via Regulation of miR-155 Expression

Zhao, H., Zhang, J., Shao, H., Liu, J., Jin, M., Chen, J., & Huang, Y. (2017) · Molecules and Cells · doi:10.14348/molcells.2017.1303 · Cited by 38 · see citing works

Sponges against miR-19 and miR-155 reactivate the p53-Socs1 axis in hematopoietic cancers

Mignacca, L., Saint‐Germain, E., Benoit, A., Bourdeau, V., Moro, A., & Ferbeyre, G. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.015 · Cited by 37 · see citing works

Epstein-Barr virus-encoded LMP1 increases miR-155 expression, which promotes radioresistance of nasopharyngeal carcinoma via suppressing UBQLN1.

Yang, F., Liu, Q., & Cm, H. (2015) · PubMed · Cited by 36 · see citing works

Anti‐miR‐155 oligonucleotide enhances chemosensitivity of U251 cell to taxol by inducing apoptosis

Meng, W., Jiang, L., Lü, L., Hu, H., Yu, H., Ding, D., Xiao, K., Zheng, W., Guo, H., & Ma, W. (2012) · Cell Biology International · doi:10.1042/cbi20100918 · Cited by 34 · see citing works

Matrix Gla protein repression by miR‐155 promotes oncogenic signals in breast cancer MCF‐7 cells

Tiago, D. M., Conceição, N., Caiado, H., Laizé, V., & Cancela, M. L. (2016) · FEBS Letters · doi:10.1002/1873-3468.12155 · Cited by 31 · see citing works

Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c

Narita, M., Shimura, E., Nagasawa, A., Aiuchi, T., Suda, Y., Hamada, Y., Ikegami, D., Iwasawa, C., Arakawa, K., Igarashi, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172115 · Cited by 31 · see citing works

miR-155 inhibitor reduces the proliferation and migration in osteosarcoma MG-63 cells

Lv, H., Guo, J., Li, S., & Jiang, D. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1942 · Cited by 25 · see citing works

miR-155 regulative network in FLT3 mutated acute myeloid leukemia

Salemi, D., Cammarata, G., Agueli, C., Augugliaro, L., Corrado, C., Bica, M. G., Raimondo, S., Marfia, A., Randazzo, V., Dragotto, P., et al. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.04.017 · Cited by 21 · see citing works

Seed targeting with tiny anti-miR-155 inhibits malignant progression of multiple myeloma cells

Feng, M., Luo, X., Gu, C., & Fei, J. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.951653 · Cited by 21 · see citing works

Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy

Mangala, L. S., Wang, H., Jiang, D., Wu, S. Y., Somasunderam, A., Volk, D. E., Lokesh, G. L.-R., Li, X., Pradeep, S., Yang, X., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.122387 · Cited by 16 · see citing works

Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy

Mangala, L. S., Wang, H., Jiang, D., Wu, S. Y., Somasunderam, A., Volk, D. E., Lokesh, G. L.-R., Li, X., Pradeep, S., Yang, X., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.87754 · Cited by 16 · see citing works

In Vitro Induction of Human Regulatory T-Cells (iTregs) Using Conditions of Low Tryptophan Plus Kynurenines

Hippen, K. L., MacMillan, M. L., Lemire, A. M., Saha, A., Hanse, E. A., Lord, C. J., Kelekar, A., O’Connor, R. S., Riley, J. L., June, C. H., et al. (2016) · Blood · doi:10.1182/blood.v128.22.1229.1229 · Cited by 3 · see citing works

PD-1/PD-L1 pathway: current researches in cancer.

Han, Y., Liu, D., & Li, L. (2020) · PubMed Central · Cited by 1,602 · see citing works

The Potential for microRNA Therapeutics and Clinical Research

Hanna, J., Hossain, G. S., & Kocerha, J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00478 · Cited by 729 · see citing works

MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies

Kim, T., & Croce, C. M. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01050-9 · Cited by 417 · see citing works

RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs

Bajan, S., & Hutvágner, G. (2020) · Cells · doi:10.3390/cells9010137 · Cited by 399 · see citing works

Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons

Akman, M., Belisario, D. C., Salaroglio, I. C., Kopecka, J., Donadelli, M., Smaele, E. D., & Riganti, C. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01824-3 · Cited by 176 · see citing works

miRNA dysregulation is an emerging modulator of genomic instability

Cardoso, A. P. F., Banerjee, M., Nail, A. N., Lykoudi, A., & States, J. C. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.004 · Cited by 169 · see citing works

An electrochemical biosensor for simultaneous detection of breast cancer clinically related microRNAs based on a gold nanoparticles/graphene quantum dots/graphene oxide film

Pothipor, C., Jakmunee, J., Bamrungsap, S., & Ounnunkad, K. (2021) · The Analyst · doi:10.1039/d1an00436k · Cited by 153 · see citing works

Anlotinib as a molecular targeted therapy for tumors (Review)

Gao, Y., Liu, P., & Shi, R. (2020) · Oncology Letters · doi:10.3892/ol.2020.11685 · Cited by 149 · see citing works

Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo

Zhupanyn, P., Ewe, A., Büch, T., Malek, A. V., Rademacher, P., Müller, C., Reinert, A., Jaimes, Y., & Aigner, A. M. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.032 · Cited by 146 · see citing works

Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response

Ashrafizadeh, M., Paskeh, M. D. A., Mirzaei, S., Gholami, M. H., Zarrabi, A., Hashemi, F., Hushmandi, K., Hashemi, M., Nabavi, N., Crea, F., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02293-6 · Cited by 147 · see citing works

The Interaction Between Two Worlds: MicroRNAs and Toll-Like Receptors

Bayraktar, R., Bertilaccio, M. T. S., & Calin, G. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01053 · Cited by 137 · see citing works

microRNA ‐based diagnostic and therapeutic applications in cancer medicine

Sempere, L. F., Azmi, A. S., & Moore, A. V. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1662 · Cited by 134 · see citing works

FTO Inhibition Enhances the Antitumor Effect of Temozolomide by Targeting MYC-miR-155/23a Cluster-MXI1 Feedback Circuit in Glioma

Li, X., Li, X., Mu, Z., Zhou, J., Zhou, P., Xie, C., & Jiang, S. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0132 · Cited by 133 · see citing works

MicroRNA and ROS Crosstalk in Cardiac and Pulmonary Diseases

Climent, M., Viggiani, G., Chen, Y., Coulis, G., & Castaldi, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124370 · Cited by 129 · see citing works

Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy

Li, Y., Duo, Y., Bi, J., Zeng, X., Mei, L., Bao, S., He, L., Shan, A., Zhang, Y., & Yu, X. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s158290 · Cited by 124 · see citing works

Paclitaxel‑resistant gastric cancer MGC‑803 cells promote epithelial‑to‑mesenchymal transition and chemoresistance in paclitaxel‑sensitive cells via exosomal delivery of miR‑155‑5p

Wang, M., Qiu, R., Yu, S., Xu, X., Li, G., Gu, R., Tan, C., Zhu, W., & Shen, B. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4601 · Cited by 124 · see citing works

Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance

dos Santos, P. W. D. S., & Almeida, F. B. D. R. (2020) · Cells · doi:10.3390/cells9061450 · Cited by 112 · see citing works

The Impact of Adipose Tissue–Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer

Cardoso, G. S. H. R., Corrêa, L. H., & Magalhães, K. G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.563816 · Cited by 107 · see citing works

Dysregulation of immunity by cigarette smoking promotes inflammation and cancer: A review

Liu, Y., Lu, L., Yang, H., Wu, X., Luo, X., Shen, J., Xiao, Z., Zhao, Y., Du, F., Chen, Y., et al. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.122730 · Cited by 104 · see citing works

Anticancer and anti-inflammatory properties of mangiferin: A review of its molecular mechanisms

Mei, S., Ma, H., & Chen, X. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.111997 · Cited by 101 · see citing works

Role of Gut Microbiota and Probiotics in Colorectal Cancer: Onset and Progression

Torres-Maravilla, E., Boucard, A.-S., Mohseni, A. H., Taghinezhad‐S, S., Cortes‐Perez, N. G., & Bermúdez‐Humarán, L. G. (2021) · Microorganisms · doi:10.3390/microorganisms9051021 · Cited by 96 · see citing works

Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update

Bayraktar, E., Bayraktar, R., Öztatlıcı, H., Lopez‐Berestein, G., Amero, P., & Rodriguez‐Aguayo, C. (2023) · Non-Coding RNA · doi:10.3390/ncrna9020027 · Cited by 86 · see citing works

The emerging role of super enhancer-derived noncoding RNAs in human cancer

Wang, Y., Nie, H., He, X., Liao, Z., Zhou, Y., Zhou, J., & Ou, C. (2020) · Theranostics · doi:10.7150/thno.49168 · Cited by 84 · see citing works

Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion

Bayraktar, R., Ivan, C., Bayraktar, E., Kanlikilicer, P., Kabil, N. N., Kahraman, N., Mokhlis, H. A., Karakaş, D., Rodriguez‐Aguayo, C., Arslan, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1959 · Cited by 82 · see citing works

The Role of Exosomal microRNA in Cancer Drug Resistance

Guo, Q.-R., Wang, H., Yan, Y.-D., Liu, Y., Su, C., Chen, H., Yan, Y., Adhikari, R., Wu, Q., & Zhang, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00472 · Cited by 81 · see citing works

Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm

Grabowska, W., Want, A., Leszek, J., & Wojda, U. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103691 · Cited by 79 · see citing works

Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer

Chen, X., Feng, L., Huang, Y., Wu, Y., & Xie, N. (2022) · Cancers · doi:10.3390/cancers15010104 · Cited by 81 · see citing works

Drug resistance‐related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies

Chen, R., Wang, G., Zheng, Y., Hua, Y., & Cai, Z. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14064 · Cited by 76 · see citing works

Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?

Zhou, D., Luan, J., Huang, C., & Li, J. (2020) · Gut and Liver · doi:10.5009/gnl20223 · Cited by 73 · see citing works

Delivery of therapeutic oligonucleotides in nanoscale

Wu, L., Zhou, W., Lin, L., Chen, A., Feng, J. C., Qu, X., Zhang, H., & Yue, J. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.05.038 · Cited by 70 · see citing works

Hepatocellular Carcinoma Cell-Derived Exosomal miR-21-5p Induces Macrophage M2 Polarization by Targeting RhoB

Yu, H., Pan, J., Zheng, S., Cai, D., Luo, A., Xia, Z., & Huang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054593 · Cited by 69 · see citing works

The Role of miR-155 in Antitumor Immunity

Kalkusova, K., Táborská, P., Stakheev, D., & Smrž, D. (2022) · Cancers · doi:10.3390/cancers14215414 · Cited by 67 · see citing works

Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155

Qian, H., Maghsoudloo, M., Kaboli, P. J., Babaeizad, A., Cui, Y., Fu, J., Wang, Q., & İmani, S. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.102123 · Cited by 62 · see citing works

Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer’s Disease

Liu, Y., Cheng, X. M., Li, H., Hui, S., Zhang, Z., Yang, X. J., & Peng, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.908076 · Cited by 61 · see citing works

Epigenetic frontiers: miRNAs, long non-coding RNAs and nanomaterials are pioneering to cancer therapy

Prabhakaran, R., Thamarai, R., Sivasamy, S., Dhandayuthapani, S., Batra, J., Kamaraj, C., Karthik, K., Shah, M. A., & Mallik, S. (2024) · Epigenetics & Chromatin · doi:10.1186/s13072-024-00554-6 · Cited by 67 · see citing works

Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker

Piao, X., Cha, E., Yun, S. J., & Kim, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041713 · Cited by 60 · see citing works

Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment

Raue, R., Frank, A.-C., Syed, S. N., & Brüne, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042210 · Cited by 60 · see citing works

Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells

Wood, C. D., Carvell, T., Gunnell, A., Ojeniyi, O. O., Osborne, C. S., & West, M. J. (2018) · Journal of Virology · doi:10.1128/jvi.00716-18 · Cited by 54 · see citing works

Luteolin inhibits respiratory syncytial virus replication by regulating the MiR-155/SOCS1/STAT1 signaling pathway

Wang, S., Ling, Y., Yao, Y., Zheng, G., & Chen, W. (2020) · Virology Journal · doi:10.1186/s12985-020-01451-6 · Cited by 56 · see citing works

Exosomal microRNA-588 from M2 polarized macrophages contributes to cisplatin resistance of gastric cancer cells

Cui, H., Rong, J., Chen, J., Jie, G., Zhu, J.-Q., Ruan, M., Zuo, R., Zhang, S., Qi, J., & Zhang, B. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i36.6079 · Cited by 53 · see citing works

Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approaches.

Bhattacharya, S., Mahato, R. K., Singh, S., Bhatti, G. K., Mastana, S., & Bhatti, J. S. (2023) · Life Science · doi:10.1016/j.lfs.2023.122110 · Cited by 48 · see citing works

Role of miRNA in Melanoma Development and Progression

Poniewierska-Baran, A., Słuczanowska-Głąbowska, S., Małkowska, P., Sierawska, O., Zadroga, Ł., Pawlik, A., & Niedźwiedzka‐Rystwej, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010201 · Cited by 52 · see citing works

Circular RNA Complement Factor H (CFH) Promotes Glioma Progression by Sponging miR-149 and Regulating AKT1

Bian, A., Wang, Y., Liu, J., Wang, X., Liu, D., Jiang, J. W., Ding, L., & Hui, X. (2018) · Medical Science Monitor · doi:10.12659/msm.910180 · Cited by 49 · see citing works

MiR-155 and other microRNAs downregulate drug metabolizing cytochromes P450 in inflammation

Kugler, N., Klein, K., & Zanger, U. M. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113725 · Cited by 49 · see citing works

MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer

Li, Y., Zhang, L., Dong, Z., Xu, H., Yan, L., Wang, W., Chen, T., Chen, C., Wang, W., Yang, Q., et al. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153405 · Cited by 46 · see citing works

Phytochemicals mediated modulation of microRNAs and long non‐coding RNAs in cancer prevention and therapy

Ruiz‐Manriquez, L. M., Estrada‐Meza, C., Benavides‐Aguilar, J. A., Ledesma‐Pacheco, S. J., Torres‐Copado, A., Serrano‐Cano, F. I., Bandyopadhyay, A., Pathak, S., Chakraborty, S., Srivastava, A., et al. (2021) · Phytotherapy Research · doi:10.1002/ptr.7338 · Cited by 44 · see citing works

Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment

Liang, X., Wang, Y., Shi, H., Dong, M., Han, H., & Li, Q. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s304526 · Cited by 41 · see citing works

Recent advances in the development and clinical application of miRNAs in infectious diseases

Nunes, S., Bastos, R., Marinho, A. C. C., do Amaral, R. V., Benício, I., de Noronha, M. A., Lírio, S., Brodskyn, C., & Tavares, N. M. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.09.005 · Cited by 45 · see citing works

Long noncoding RNA MIR155HG facilitates pancreatic cancer progression through negative regulation of miR‐802

Qin, Y., Liu, X., Pan, L., Zhou, R., & Zhang, X. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29060 · Cited by 40 · see citing works

MicroRNAs in Cancer and Cardiovascular Disease

Ilieva, M. S., Panella, R., & Uchida, S. (2022) · Cells · doi:10.3390/cells11223551 · Cited by 40 · see citing works

Dual miRNA-Triggered DNA Walker Assisted by APE1 for Specific Recognition of Tumor Cells

Zhou, Q., Li, T., Li, X., Wei, L.-T., Luo, J., Bai, L., Duan, W., Xie, B., Sun, B., Chen, J.-X., et al. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c00554 · Cited by 38 · see citing works

miR‐155expression in antitumor immunity: The higher the better?

Michaille, J., Awad, H., Fortman, E. C., Efanov, A. A., & Tili, E. (2018) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22698 · Cited by 37 · see citing works

Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer

Ebrahimi, N., Faghihkhorasani, F., Fakhr, S. S., Moghaddam, P. R., Yazdani, E., Kheradmand, Z., Rezaei-Tazangi, F., Adelian, S., Mobarak, H., Hamblin, M. R., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04552-3 · Cited by 36 · see citing works

Epigenetic regulation by quercetin: a comprehensive review focused on its biological mechanisms

Zhu, J., Cheng, X., Naumovski, N., Hu, L. T., & Wang, K. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2278760 · Cited by 36 · see citing works

Myocardial hypertrophy is improved with berberine treatment via long non-coding RNA MIAT-mediated autophagy

Zeng, Z., Pan, Y., Wu, W., Li, L., Wu, Z., Zhang, Y., Deng, B., Wei, S., Zhang, W., Lin, F., et al. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13170 · Cited by 36 · see citing works

miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells

Li, Y., Gong, P., Hou, J., Huang, W. Q., Ma, X., Wang, Y., Li, J., Cui, X., & Li, N. (2018) · Journal of Immunology Research · doi:10.1155/2018/7498514 · Cited by 34 · see citing works

The role of miR-155-5p in inflammation and mechanical loading during intervertebral disc degeneration

Cazzanelli, P., Lamoca, M., Hasler, J., Hausmann, O. N., Mesfin, A., Puvanesarajah, V., Hitzl, W., & Wuertz‐Kozak, K. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01803-7 · Cited by 33 · see citing works

Identification of RCC Subtype-Specific microRNAs–Meta-Analysis of High-Throughput RCC Tumor microRNA Expression Data

Kajdasz, A., Majer, W., Kluzek, K., Sobkowiak, J., Milecki, T., Derebecka, N., Kwias, Z., Bluyssen, H. A. R., & Wesoły, J. (2021) · Cancers · doi:10.3390/cancers13030548 · Cited by 33 · see citing works

MicroRNAs in gray and white matter multiple sclerosis lesions: impact on pathophysiology

Teuber‐Hanselmann, S., Meinl, E., & Junker, A. (2020) · The Journal of Pathology · doi:10.1002/path.5399 · Cited by 32 · see citing works

miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities

Huang, W., Paul, D., Călin, G. A., & Bayraktar, R. (2023) · Cells · doi:10.3390/cells13010084 · Cited by 33 · see citing works

Functional Nucleic‐Acid‐Decorated Spherical Nanoparticles: Preparation Strategies and Current Applications in Cancer Therapy

Zhu, M. P., & Wang, S. (2021) · Small Science · doi:10.1002/smsc.202000056 · Cited by 31 · see citing works

Mechanism of exosomal miR-155 derived from bone marrow mesenchymal stem cells on stemness maintenance and drug resistance in myeloma cells

Gao, X., Zhou, J., Wang, J., Dong, X., Chang, Y., & Jin, Y. (2021) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-021-02793-9 · Cited by 31 · see citing works

miRNAs in Drug Response Variability: Potential Utility as Biomarkers for Personalized Medicine

Latini, A., Borgiani, P., Novelli, G., & Ciccacci, C. (2019) · Pharmacogenomics · doi:10.2217/pgs-2019-0089 · Cited by 31 · see citing works

miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer

Hon, K. W., Abu, N., Mutalib, N. A., & Jamal, R. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00846 · Cited by 30 · see citing works

The Interplay between MicroRNAs and the Components of the Tumor Microenvironment in B-Cell Malignancies

El‐Daly, S. M., Bayraktar, R., Anfossi, S., & Călin, G. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093387 · Cited by 31 · see citing works

Inflammation and Inflammasomes: Pros and Cons in Tumorigenesis

Balahura, L.-R., Șelaru, A., Dinescu, S., & Costache, M. (2020) · Journal of Immunology Research · doi:10.1155/2020/2549763 · Cited by 29 · see citing works

MiR-526b-3p Attenuates Breast Cancer Stem Cell Properties and Chemoresistance by Targeting HIF-2α/Notch Signaling

Liu, J., Li, W., Yang, Y., Qi, Y.-B., Cheng, Y. S., & Wu, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.696269 · Cited by 29 · see citing works

AntimiR-155 Cyclic Peptide–PNA Conjugate: Synthesis, Cellular Uptake, and Biological Activity

Soudah, T., Khawaled, S., Aqeilan, R. I., & Yavin, E. (2019) · ACS Omega · doi:10.1021/acsomega.9b01697 · Cited by 29 · see citing works

Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway

Li, X., He, J., Ren, X., Zhao, H., & Zhao, H. (2020) · Diagnostic Pathology · doi:10.1186/s13000-020-01056-1 · Cited by 29 · see citing works

MicroRNAs in extracellular vesicles: A potential role in cancer progression

Parashar, D., Mukherjee, T., Gupta, S. K., Kumar, U., & Das, K. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111263 · Cited by 27 · see citing works

Extracellular Vesicles Loaded miRNAs as Potential Modulators Shared Between Glioblastoma, and Parkinson’s and Alzheimer’s Diseases

Thomas, L., Florio, T., & Perez-Castro, C. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.590034 · Cited by 28 · see citing works

Triclosan induced zebrafish immunotoxicity by targeting miR-19a and its gene socs3b to activate IL-6/STAT3 signaling pathway

Zhao, C., Xie, R., Qian, Q., Yan, J., Wang, H., & Wang, X. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.152916 · Cited by 27 · see citing works

Radiation therapy for triple-negative breast cancer: emerging role of microRNAs as biomarkers and radiosensitivity modifiers. A systematic review

To, N. H., Nguyen, H. Q., Thiolat, A., Liu, B., Cohen, J. L., Radosevic‐Robin, N., & Belkacémi, Y. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06533-3 · Cited by 26 · see citing works

Drug Resistance: The Role of Exosomal miRNA in the Microenvironment of Hematopoietic Tumors

Cariello, M., Squilla, A., Piacente, M., Venutolo, G., & Fasano, A. (2022) · Molecules · doi:10.3390/molecules28010116 · Cited by 27 · see citing works

Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer

Dogra, P., Shinglot, V., Ruiz-Ramírez, J., Cave, J., Butner, J. D., Schiavone, C., Duda, D. G., Kaseb, A. O., Chung, C. D., Koay, E. J., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02060-5 · Cited by 25 · see citing works

Circulatory miRNA-155, miRNA-21 target PTEN expression and activity as a factor in breast cancer development

Ali, S. A., Abdulrahman, Z. F. A., & Faraidun, H. (2020) · Cellular and Molecular Biology · doi:10.14715/cmb/2020.66.7.8 · Cited by 25 · see citing works

Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer’s disease

Liu, J.-J., Long, Y.-F., Xu, P., Guo, H.-D., & Cui, G.-H. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01264-z · Cited by 25 · see citing works

LncRNA-miRNA interaction is involved in colorectal cancer pathogenesis by modulating diverse signaling pathways

Alshahrani, S. H., Al-Hadeithi, Z. S. M., Almalki, S. G., Malviya, J., Hjazi, A. M., Mustafa, Y. F., Alawady, A. H. R., Alsaalamy, A. H., Joshi, S. K., & Alkhafaji, A. T. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154898 · Cited by 25 · see citing works

miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2

Fuentes‐Mattei, E., Bayraktar, R., Manshouri, T., Silva, A. M., Ivan, C., Gulei, D., Fabris, L., do Amaral, N. S., Mur, P., Perez, C., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.121781 · Cited by 25 · see citing works

Shikonin Causes an Apoptotic Effect on Human Kidney Cancer Cells through Ras/MAPK and PI3K/AKT Pathways

Király, J., Szabó, E., Fodor, P., Fejes, Z., Nagy, B., Juhász, É., Vass, A., Choudhury, M., Kónya, G., Halmos, G., et al. (2023) · Molecules · doi:10.3390/molecules28186725 · Cited by 24 · see citing works

Dapagliflozin prevents kidney podocytes pyroptosis via miR-155-5p/HO-1/NLRP3 axis modulation

Zhang, Z.-W., Ming-qiu, T., Liu, W., Song, Y., Gao, M.-J., Ni, P., Zhang, D., Mo, Q., & Zhao, B. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111785 · Cited by 24 · see citing works

Chicken gga-miR-1306-5p targets Tollip and plays an important role in host response against Salmonella enteritidis infection

Sun, W., Liu, R., Li, P., Li, Q., Cui, H., Zheng, M., Wen, J., & Zhao, G. (2019) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-019-0365-2 · Cited by 24 · see citing works

MiR ‐155 regulates M2 polarization of hepatitis B virus‐infected tumour‐associated macrophages which in turn regulates the malignant progression of hepatocellular carcinoma

Fei, Y., Wang, Z., Huang, M., Wu, X., Hu, F., Zhu, J., Yu, Y., Shen, H., Wu, Y., Xie, G.-L., et al. (2023) · Journal of Viral Hepatitis · doi:10.1111/jvh.13809 · Cited by 25 · see citing works

Aptamer‐RIBOTAC Strategy Enabling Tumor‐Specific Targeted Degradation of MicroRNA for Precise Cancer Therapy

Fang, Y., Wu, Q., Wang, F., Liu, Y., Zhang, H., Yang, C. J., & Zhu, Z. (2024) · Small Methods · doi:10.1002/smtd.202400349 · Cited by 24 · see citing works

Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses

Chauhan, P. K., Pramodh, S., Hussain, A., Elsori, D. H., Lakhanpal, S., Kumar, R., Alsaweed, M., Iqbal, D., Pandey, P., Othaim, A. A., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1397945 · Cited by 24 · see citing works

MiRNA-155: A double-edged sword in colorectal cancer progression and drug resistance mechanisms

Hussen, B. M., Sulaiman, S. H. A., Abdullah, S. R., Hidayat, H. J., Khudhur, Z. O., Eslami, S., Samsami, M., & Taheri, M. N. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140134 · Cited by 23 · see citing works

Engineered Biosensors for Diagnosing Multidrug Resistance in Microbial and Malignant Cells

Jha, N. G., Dkhar, D. S., Singh, S. K., Malode, S. J., Shetti, N. P., & Chandra, P. (2023) · Biosensors · doi:10.3390/bios13020235 · Cited by 24 · see citing works

Functional role of miR‑155 in physiological and pathological processes of liver injury (Review)

Feng, X., Bao, J., Song, C., Xie, L., Tan, X., Li, J., Jia, H., Tian, M., Qi, J., Qin, C., et al. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12353 · Cited by 22 · see citing works

Tumor-Targeted miRNA Nanomedicine for Overcoming Challenges in Immunity and Therapeutic Resistance

Parayath, N. N., Gandham, S. K., & Amiji, M. M. (2022) · Nanomedicine · doi:10.2217/nnm-2022-0130 · Cited by 22 · see citing works

Single Shot vs. Cocktail: A Comparison of Mono- and Combinative Application of miRNA-Targeted Mesyl Oligonucleotides for Efficient Antitumor Therapy

Gaponova, S., Patutina, O., Васильевна, С. А., Burakova, E. A., Savin, I. A., Markov, A. V., Shmendel, E. V., Maslov, M. A., Stetsenko, D. A., Vlassov, V. V., et al. (2022) · Cancers · doi:10.3390/cancers14184396 · Cited by 21 · see citing works

miR‑155 inhibition represents a potential valuable regulator in mitigating myocardial hypoxia/reoxygenation injury through targeting BAG5 and MAPK/JNK signaling

Xi, J., Li, Q., Li, B., & Li, N. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.10924 · Cited by 22 · see citing works

lncRNA CASC2 Enhances 131I Sensitivity in Papillary Thyroid Cancer by Sponging miR‐155

Tao, L., Tian, P., Yang, L., & Guo, X. (2020) · BioMed Research International · doi:10.1155/2020/7183629 · Cited by 19 · see citing works

MiR-195-5p inhibits proliferation and invasion of nerve cells in Hirschsprung disease by targeting GFRA4

Wang, G., Wang, H., Zhang, L., Guo, F., Wu, X., & Liu, Y. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04055-y · Cited by 19 · see citing works

PBMC gene expression profiles of female Bangladeshi adults chronically exposed to arsenic-contaminated drinking water

Chen, Q. Y., Shen, S., Sun, H. Y., Wu, F., Kluz, T., Kibriya, M. G., Chen, Y., Ahsan, H., & Costa, M. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.113672 · Cited by 19 · see citing works

Upregulation of Akt/Raptor signaling is associated with rapamycin resistance of breast cancer cells

Shchegolev, Y. Y., Sorokin, D. V., Scherbakov, A. M., Shunaev, A., Andreeva, O. E., Mikhaevich, E. I., Gudkova, M. V., Bure, I. V., Berstein, L. M., Nemtsova, M. V., et al. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109243 · Cited by 18 · see citing works

A Literature Review on the Antiviral Mechanism of Luteolin

Lu, P., Zhang, T., Ren, Y., Rao, H., Lei, J., Zhao, G., Wang, M., Gong, D., & Cao, Z. (2023) · Natural Product Communications · doi:10.1177/1934578x231171521 · Cited by 19 · see citing works

Unraveling Therapeutic Opportunities and the Diagnostic Potential of microRNAs for Human Lung Cancer

Sweef, O., Zaabout, E., Bakheet, A., Halawa, M. R., Gad, I., Akela, M. A., Tousson, E., Abdelghany, A., & Furuta, S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082061 · Cited by 18 · see citing works

Cancer drug resistance related microRNAs: recent advances in detection methods

Hu, X., Song, Z., Yang, Z.-W., Li, J., Liu, J., & Wang, H. (2022) · The Analyst · doi:10.1039/d2an00171c · Cited by 18 · see citing works

Regulation of Oncogenic Targets by Tumor-Suppressive miR-150-3p in Lung Squamous Cell Carcinoma

Mizuno, K., Tanigawa, K., Misono, S., Suetsugu, T., Sanada, H., Uchida, A., Kawano, M., Machida, K., Asai, S., Moriya, S., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9121883 · Cited by 16 · see citing works

MicroRNA-155-5p in pathogenesis of cancer

Zborovskaya, I. B., & Komelkov, A. V. (2017) · Advances in molecular oncology · doi:10.17650/2313-805x-2017-4-3-27-36 · Cited by 4 · see citing works

miR-155 as a novel clinical target for hematological malignancies

Witten, L., & Slack, F. J. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz183 · Cited by 103 · see citing works

The Role of miR-155 in Antitumor Immunity

Kalkusova, K., Táborská, P., Stakheev, D., & Smrž, D. (2022) · Cancers · doi:10.3390/cancers14215414 · Cited by 67 · see citing works

MiR‐145 in cancer therapy resistance and sensitivity: A comprehensive review

Xu, W., Hua, Y.-T., Deng, F., Wang, D., Wu, Y. F., Zhang, W., & Tang, J. (2020) · Cancer Science · doi:10.1111/cas.14517 · Cited by 66 · see citing works

The multiple roles of microRNA-155 in oncogenesis

Higgs, G., & Slack, F. (2013) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-3-17 · Cited by 137 · see citing works